Use of Idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. A multicentric experience in Spain.
Crespo-Leiro MG, López-Vilella R, López Granados A, Mirabet-Pérez S, Díez-López C, Barge-Caballero E, Segovia-Cubero J, González-Vilchez F, Rangel-Sousa D, Blasco-Peiró T, de la Fuente-Galán L, Díaz-Molina B, Zatarain-Nicolás E, Carrasco Ávalos F, Almenar-Bonet L.
Crespo-Leiro MG, et al.
Clin Transplant. 2019 Dec;33(12):e13748. doi: 10.1111/ctr.13748. Epub 2019 Nov 18.
Clin Transplant. 2019.
PMID: 31670852